Colchicine Tiofarma 500 microgram Tablets

DRUG4 trials

Sponsors

Universitair Ziekenhuis Gent, Az St-Jan Brugge-Oostende A.V., University College Dublin, Sint Maartenskliniek, Hamilton Health Sciences Corporation

Conditions

Coronary artery diseaseOsteoarthritisPeripheral arterial diseaseStroke

Phase 2

CONCISE COlchicine iN Circulating Inflammatory markers after StrokE

CompletedCTIS2023-506967-33-00

University College DublinStroke

End: 2024-11-19Target: 120Updated: 2024-04-18

Phase 3

COLchicine in BElgium in patients with coronary artery disease after Percutaneous Coronary Intervention

RecruitingCTIS2023-505028-74-00

Universitair Ziekenhuis Gent, Az St-Jan Brugge-Oostende A.V.Coronary artery disease

Start: 2024-01-29Target: 2770Updated: 2025-09-08

The Effect of ColcHicine on the incidence of knee or hip replacements: a randomized, double-blind, multicentre study in symptomatic knee or hip Osteoarthritis – the ECHO trial

RecruitingCTIS2024-511359-16-00

Sint MaartenskliniekOsteoarthritis

Start: 2025-01-17Target: 1200Updated: 2025-08-19

Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial- LEADER PAD

RecruitingCTIS2024-512091-35-01

Hamilton Health Sciences CorporationPeripheral arterial disease

Start: 2025-06-17Target: 1798Updated: 2025-11-26

Related Papers

Design of a randomised, placebo-controlled, double-blind multicentre study assessing the effect of colchicine on the incidence of knee or hip replacements in symptomatic knee or hip osteoarthritis: the ECHO trial

BMJ Open2025-04-011 citations